SuperworthHerbalife EPS HLF
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- $1.55
- Latest quarter, Q2 FY26
- −$0.25
- −152% on a year earlier
- Fiscal year 2025
- $2.20
- −12% on the year before
Herbalife's earnings per share was $1.55 over the twelve months to Jun 30, 2026, down 51% on a year earlier.
In its latest quarter, Q2 FY26, it was −$0.25, down 152% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 5% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $2.20 | −12% |
| FY2024 | $2.49 | +75% |
| FY2023 | $1.42 | −56% |
| FY2022 | $3.22 | −21% |
| FY2021 | $4.10 | +48% |
| FY2020 | $2.77 | +27% |
| FY2019 | $2.18 | +10% |
| FY2018 | $1.99 | +67% |
| FY2017 | $1.20 | −21% |
| FY2016 | $1.50 | −24% |
| FY2015 | $1.98 | +17% |
| FY2014 | $1.70 | −31% |
| FY2013 | $2.46 | +24% |
| FY2012 | $1.98 | +18% |
| FY2011 | $1.67 | +41% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.25 | −152% | $1.55 | |
| Q1 FY26 | $0.57 | +16% | $2.28 | |
| Q4 FY25 | $0.81 | −53% | $2.20 | |
| Q3 FY25 | $0.42 | −9% | $3.13 | |
| Q2 FY25 | $0.48 | +860% | $3.17 | |
| Q1 FY25 | $0.49 | +104% | $2.74 | |
| Q4 FY24 | $1.74 | +1640% | $2.49 | |
| Q3 FY24 | $0.46 | +7% | $0.85 | |
| Q2 FY24 | $0.05 | −92% | $0.82 | |
| Q1 FY24 | $0.24 | −17% | $1.37 | |
| Q4 FY23 | $0.10 | −82% | $1.42 | |
| Q3 FY23 | $0.43 | −48% | $1.87 |
Against its peers
Companies in Healthcare nearest Herbalife's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| HLFHerbalife | $1.55 | −51% a year |
| PCRXPacira BioSciences | $0.35 | |
| ANABAnaptysbio | $4.57 | |
| PNTGPennant | $0.90 | +15% a year |
| CNMDCONMED | $1.85 | −48% a year |
| EYENational Vision | $0.61 | |
| USPHU S Physical Therapy | $0.88 | −63% a year |
| TRUPTrupanion | $0.53 | +104% a year |
| CDRECadre | $0.81 | −14% a year |
| BVSBioventus | $0.77 | |
| PAHCPhibro Animal Health | $2.44 | +107% a year |
| Peer median | $0.84 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Herbalife
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.